28 Jun 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215921
24 Aug 2022
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215834
13 Dec 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/actinium-pharmaceuticals-inc-announces-greater-difference-of-approximately-5x-for-iomab-b-vs-control-arm-in-the-number-of-patients-potentially-evaluable-for-the-primary-endpoint-of-the-pivotal-phase-3-sierra-trial-at-the-63rd-as-301442794.html
20 Aug 2021
// GLOBALGENES
https://globalgenes.org/2021/08/19/nice-recommends-first-treatment-for-rare-blood-disorder/
19 Aug 2021
// NICE
https://www.nice.org.uk/news/article/nice-recommends-first-treatment-for-rare-blood-disorder
18 Jun 2021
// Angus Liu FIERCEPHARMA
https://www.fiercepharma.com/marketing/blueprint-challenges-novartis-new-ayvakit-nod-blood-disorders-more-competition-to-follow
LOOKING FOR A SUPPLIER?